Suven Life Sciences Limited — Important, 04-06-2025: Updates

Suven Life Sciences has announced a board meeting to consider a preferential issue of 29.85 lakh convertible warrants to Abakkus Diversified Alpha Fund, potentially raising the fund’s stake to 1.06% after conversion. This capital raise is structured as a strategic allotment, with no changes to previously disclosed terms and no immediate operational or financial updates.